Alemtuzumab
ATC L04AG06 · 10 markets · 21 records
AU 5 records · 4 strengths
- 12 mg/1.2 mLinjectionLEMTRADA
- 30 mginjectionMABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial
- 10 mg/mLinjectionLEMTRADA alemtuzumab 10 mg/mL injection concentrated vial
Records without a stated strength · 1 LEMTRADA、MABCAMPATH
GB 3 records · 3 strengths
- 12 mg/1.2 mLinjectionLemtrada 12mg/1.2ml concentrate for solution for infusion vials
- 30 mg/3 mLinjectionMabCampath 30mg/3ml concentrate for solution for infusion ampoules
- 30 mg/1 mLinjectionMabCampath 30mg/1ml concentrate for solution for infusion vials
US 2 records · 2 strengths
- 12 mg/1.2 mLinjectionLEMTRADA
- 30 mginjectionCampath
CA 2 records · 2 strengths
- 30 mgliquidMABCAMPATH
- 10 mg/1 mLliquidLEMTRADA
SG 1 records · 1 strengths
- 12 mg/1.2 mLinjectionLEMTRADA 12mg concentrate for solution for infusion
ES 1 records · 1 strengths
- 12 mginjectionLEMTRADA
MX 1 records · 1 strengths
Records without a stated strength · 1 LEMTRADA
TW 1 records · 1 strengths
- 12 mginjectionLEMTRADA 12mg concentrate for solution for infusion任力達濃縮輸注液12毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 LEMTRADA 12mg concentrate for solution for infusion
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 LEMTRADA
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 mg/1.2 mL injection | LEMTRADA | Lemtrada 12mg/1.2ml concentrate for solution for infusion vials | LEMTRADA | LEMTRADA 12mg concentrate for solution for infusion | ||||||
| 12 mg injection | LEMTRADA | LEMTRADA 12mg concentrate for solution for infusion 任力達濃縮輸注液12毫克 | ||||||||
| 30 mg injection | Campath | MABCAMPATH alemtuzumab 30mg/mL concentrate solution for infusion vial | ||||||||
| 30 mg liquid | MABCAMPATH | |||||||||
| 10 mg/1 mL liquid | LEMTRADA | |||||||||
| 30 mg/3 mL injection | MabCampath 30mg/3ml concentrate for solution for infusion ampoules | |||||||||
| 30 mg/1 mL injection | MabCampath 30mg/1ml concentrate for solution for infusion vials | |||||||||
| 10 mg/mL injection | LEMTRADA alemtuzumab 10 mg/mL injection concentrated vial | |||||||||
unknown | LEMTRADA MABCAMPATH | LEMTRADA 12mg concentrate for solution for infusion | LEMTRADA | |||||||
liquid | LEMTRADA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · ES · MX · TW and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · ES · MX · TW que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · ES · MX · TW 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 CA · ES · MX · TW 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.